2024-10-30 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**Company Overview:** Intuitive Surgical Inc. is a leading provider of robotic-assisted minimally invasive surgical systems, instruments, and accessories.

**Performance Summary:**

* **Performance vs. S&P 500 (VOO):** ISRG has significantly outperformed the S&P 500, with a cumulative return of 373.73% compared to 136.74% for the VOO. This represents a substantial outperformance of 236.99%, placing it at the 81.65th percentile of its historical performance range against the VOO.
* **Recent Price Movements:** 
    * Closing Price: $516.31 (Last-market: $516.25)
    * 5-day Moving Average: $512.53
    * 20-day Moving Average: $494.79
    * 60-day Moving Average: $485.38
* **Technical Indicators:**
    * RSI: 64.85 (slightly overbought territory)
    * PPO: 0.44 (positive momentum)
    * Delta_Previous_Relative_Divergence: 6.42 (+) (indicating short-term upward trend)
    * Expected_Return: 12.49% (potential for outperformance over the long-term)
* **Recent Earnings and Outlook:**
    * **Earnings:** 
        | Date | EPS | Revenue |
        |---|---|---|
        | 2024-10-18 | 1.59 | $2.04 B |
        | 2024-07-19 | 1.48 | $2.01 B |
        | 2024-04-19 | 1.54 | $1.89 B |
        | 2023-10-20 | 1.18 | $1.74 B |
        | 2024-10-18 | 1.18 | $1.74 B |
    * **Analysis:** ISRG has consistently exceeded earnings expectations, showing steady growth in both earnings and revenue. The most recent earnings report for Q3 2024 (ended 2024-10-18) was slightly above analyst estimates, indicating continued strong performance.
* **Financial Information:**
    * **Revenue and Profitability:**
        | Quarter | Revenue | Profit Margin |
        |---|---|---|
        | 2024-09-30 | $2.04B | 67.41% |
        | 2024-06-30 | $2.01B | 68.30% |
        | 2024-03-31 | $1.89B | 65.87% |
        | 2023-12-31 | $1.93B | 66.24% |
        | 2023-09-30 | $1.74B | 66.94% |
    * **Capital and Profitability:**
        | Quarter | Equity | ROE |
        |---|---|---|
        | 2024-09-30 | $15.58B | 3.63% |
        | 2024-06-30 | $14.71B | 3.58% |
        | 2024-03-31 | $13.96B | 3.90% |
        | 2023-12-31 | $13.31B | 4.56% |
        | 2023-09-30 | $12.54B | 3.32% |
    * **Analysis:** ISRG demonstrates consistent profitability with high profit margins, suggesting efficient operations. While ROE fluctuates slightly, it generally reflects a strong return on equity. 
* **News and Recent Issues:**
    * **Recent Earnings News:** The most recent earnings report was covered by several publications like Shacknews, highlighting the company's strong performance and continued growth.
    * **Recent Market Outlook:** ISRG remains a popular pick among analysts, with several analysts issuing "buy" ratings and bullish outlooks for the company.
    * **Analyst Opinions and Performance Highlights:** Finbold highlights ISRG's market-leading position, impressive growth trajectory, and robust financial performance. Several analysts also point to the growing demand for minimally invasive surgical procedures as a key driver for the company's future growth. 

**Conclusion:**

Intuitive Surgical is a strong performer in the medical device industry. The company has consistently delivered robust growth in earnings and revenue, coupled with a high profit margin and solid financial health. The stock has significantly outperformed the S&P 500, showing potential for long-term outperformance. Technical indicators are positive, with a slight overbought signal on the RSI.  While the company faces competition and the evolving regulatory landscape, ISRG's market-leading position and growing demand for minimally invasive surgery suggest a positive outlook for the future. This makes ISRG a compelling investment option, especially for long-term investors seeking exposure to the healthcare sector. 
